Главная страницаLBank Stocks
Beta Bionics, Inc. Common Stock
Beta Bionics, Inc. Common Stock

Beta Bionics, Inc. Common Stock (BBNX)

24HВысокий$22.1624HНизкий$21.10
$21.91
+0.03%

Последнее обновление: 2026-09-19 11:07:02

Симуляция графика K-линий, фактические данные указаны на торговой странице

Ключевые данные

Открытие вчера
$21.30
Пред. закрытие
$21.91
Вчерашний диапазон
$21.10 - $22.16
Диапазон 52 нед.
$8.80 - $32.71
Объем торговли
879.096K
МС
$1.128B
P/E
--
EPS
$-1.55

Обзор компании

NASDAQ

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. The company is headquartered in Irvine, California.

СекторHEALTHCARE
ОтрасльMEDICAL DEVICES
Штаб-квартира11 HUGHES, IRVINE, CA, UNITED STATES, 92618
СтранаUSA
Дата листинга2025-01-30
Конец финансового года2026-06-30
Акции в обращении52.642M
Код CIK1674632

Финансовые показатели

Индикатор2026-03-312025-12-312025-09-302025-06-30
Доход$27.626M$32.121M$27.253M$23.238M
Операционные расходы$11.189M$13.177M$12.134M$10.735M
Чистая прибыль-$21.895M-$13.466M-$14.209M-$16.869M
Чистая рентабельность-79.3%-41.9%-52.1%-72.6%
Прибыль на акцию--------
EBITDA-$21.224M-$12.53M-$13.526M-$16.216M
Эффективная налоговая ставка---0.0%----

Часто задаваемые вопросы

BBNX operates in the [sector] sector, within the [industry] industry. The company's core business involves [key activities], with a focus on [main products/services]. It generates revenue primarily through [main revenue drivers], making it an important entity in its market space.
BBNX is part of the [sector] sector, specifically within the [industry] industry. Its operations are aligned with trends and demands in this business landscape, highlighting its role in [sector-specific activities].
Investing in BBNX presents opportunities such as [specific opportunities, if known]. However, it also carries risks, including market volatility, competition within the [industry], and potential shifts in [relevant external factors]. Investors should evaluate these elements when considering the stock.
At present, BBNX [does/does not] offer dividends to its shareholders. This decision reflects its financial strategy and allocation priorities, which may focus on [growth, reinvestment, etc.]. Investors seeking income from dividends should factor this into their evaluation.
BBNX competes with several companies within the [industry] industry. Key competitors include [competitor names, if known]. Its ability to differentiate through [specific advantage] is a critical aspect of its performance in the competitive market.
BBNX primarily generates revenue through [main revenue streams]. These include [specific methods, if applicable]. Its business model is designed to capitalize on [industry-specific trends], which drives profitability.
Investors considering BBNX should examine elements such as its earnings reports, valuation metrics, and price trends compared to industry benchmarks. Other key factors include its growth potential, market share, and any financial risks it faces.
External factors such as regulatory changes, market demand, and macroeconomic conditions significantly influence BBNX's performance. The company's adaptability to such influences is key to maintaining its competitive edge.
Предупреждение о рисках
  1. 1.Цены на акции могут сильно колебаться, инвестируйте осторожно. Прошлые результаты не гарантируют будущую доходность.
  2. 2.Торговля цифровыми активами сопряжена с рыночными, техническими и иными рисками. Пожалуйста, принимайте взвешенные решения и рационально распределяйте активы.
  3. 3.Информация на этой странице предназначена только для ознакомления и не является инвестиционной рекомендацией.